Blood Clots (cont.)
IN THIS ARTICLE
Blood Clot Medication
The treatment of blood clots often is directed at interfering with the normal clotting mechanism of the body. Different medications may be used to block specific factors in the clotting cascade and are chosen based upon the disease or illness being treated and other underlying medical issues that are present in the individual patient.
Aspirin is commonly used to decrease platelet function in the treatment of heart attack and stroke. Other anti-platelet drugs include clopidogrel (Plavix) ticlopidine (Ticlid) and aspirin and dipyridamole (Aggrenox).
Warfarin (Coumadin) acts as a blood thinner by blocking clotting factors (II, VII, IX and X) that depend upon vitamin K. Every patient is unique when it comes to the dosing requirements for warfarin (Coumadin), and blood tests are routinely done to make certain that the blood is anti-coagulated to the appropriate level. There are numerous drug interactions with this medication that can cause the blood to become "too thin" such as some antibiotics. Warfarin (Coumadin) dosing always needs to be monitored by a healthcare professional, and a patient should never alter the dose of this medication without consulting with their healthcare professional.
Newer Factor Xa inhibitor medications have been approved for the treatment of certain types of atrial fibrillation, deep venous thrombosis and pulmonary embolism. They begin working almost immediately and do not need blood tests to monitor their activity. Medications in this class of anticoagulants include apixaban (Eliquis), rivaroxaban (Xarelto), and edoxaban (Savaysa). Dabigatran (Pradaxa) also is an alternative anticoagulation medication that is a direct thrombin inhibitor. As opposed to warfarin, which can have its anticoagulation activity reversed, at present there is no reversal agent available in the United States for Factor Xa and thrombin inhibitor medications.
Heparin works by inactivating thrombin and factor X. It is an injectable medication available for use intravenously or as a low molecular weight medication called enoxaparin (Lovenox) or fondaparinux (Arixtra), which can be injected subcutaneously (under the skin). Heparin is often the first line drug in treating deep venous thrombosis and pulmonary embolus and is used routinely as part of the heart attack treatment protocol.
Tissue plasminogen activator (tPA or TNK) may be used to dissolve blood clots that are life-threatening and are most often used for clots that occlude arteries in situations such as stroke or heart attack; there are occasional instances in which the drug is used for major vein obstruction. The medication can be injected into an intravenous line that has been started in a vein of the arm, or it may be dripped directly into the clot. This requires specialized critical care technology and physician skill to thread a catheter to the site of blockage to deliver the clot-busting medication. Decisions regarding the use of this drug are individualized for the specific patient and situation.
Medically Reviewed by a Doctor on 8/27/2015
Must Read Articles Related to Blood Clots
Patient Comments & Reviews
The eMedicineHealth doctors ask about Blood Clots:
Blood Clots - Treatment
Please share your experience with treatment for a condition caused by blood clots.
Blood Clots - Describe Your Experience
Please describe your experience with Blood Clots.
Blood Clots - Cause
What was the cause of your blood clots?
Blood Clots - Surgery
Please share your experience with surgery a condition caused by blood clots.